Dr. Carter acknowledges that this is an X-factor in the ARRA process. “We say thanks to Congress for allowing us to do something really special, but there is no question that there may be problems two years from now.”
Nevertheless, rheumatology researchers are making good use of the ARRA funds to launch new research projects, support ongoing investigations, and create partnerships and consortia to further understanding of rheumatic disease.
ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE
Kurt Ullman is a freelance writer based in Indiana.